<DOC>
	<DOCNO>NCT00298285</DOCNO>
	<brief_summary>The primary aim determine rate major bleed blood clot use enoxaparin bridge oral blood thin medication patient undergone mechanical valve replacement .</brief_summary>
	<brief_title>ABRIDGE : Low Molecular Weight Heparin Bridging Patients After Mechanical Valve Replacement</brief_title>
	<detailed_description>Patients undergo mechanical heart valve replacement usually place long-term oral anticoagulation ( blood thin ) medication prevent blood clot form mechanical valve . This start hospital intravenous unfractionated heparin ; patient must remain hospital unfractionated heparin . At time , oral blood thinner start ( warfarin ) . This process commonly refer `` bridging . '' Once warfarin reach proper level , intravenous heparin stop . This single center , non-randomized pilot study use twice day enoxaparin injection place unfractionated heparin bridge warfarin therapy . A total approximately 100 patient enrol . Patients instruct give enoxaparin injection home . Blood drawn every 1-2 day monitor warfarin level . Once discharge , patient continue blood level check warfarin correct level , point enoxaparin discontinue . All patient develop sign symptom stroke abnormal blood clotting ask return echocardiogram . An echocardiogram 12-lead ECG do approximately 30 day start study . Additionally first 100 consecutive patient fit inclusion criterion consent enoxaparin strategy ask enter registry monitor hospital stay information routine 30 day follow-up visit collect .</detailed_description>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients meet follow consider enrollment . 1 . Male nonpregnant female ( negative pregnancy test require woman child bear potential ) ≥ 18 age able provide inform consent able selfadminister enoxaparin . 2 . Body weight ≥ 45kg ≤ 150kg . 3 . Patients post prosthetic mechanical valve surgery need oral anticoagulation discharge hospital . One undergone valve replacement mechanical prosthesis mitral position . One undergone valve replacement mechanical prosthesis aortic position . One undergone valve replacement mechanical prosthesis tricuspid position . Patients follow eligible enrollment study : 1 . Contraindication sensitivity unfractionated heparin/ low molecular weight heparin : history heparin associate thrombocytopenia , heparin induce thrombocytopenia , heparin induce thrombotic thrombocytopenia syndrome ; 2 . History , current , cardiogenic shock ; 3 . Active endocarditis ( require &gt; 4 week antibiotic ) ; 4 . Active bleed bleeding diathesis ; 5 . History gastrointestinal bleeding /or endoscopically verify ulcer disease within last three month ; 6 . Known proliferative diabetic retinopathy history intraocular bleeding ; 7 . Ischemic stroke previous three month hemorrhagic stroke , know brain tumor , intracranial aneurysm intracranial AV malformation ; 8 . Renal insufficiency ( cr clearance &lt; 30 cc/min ) , cr clearance calculation : Women = 0.85 x ( 140 age ) x body weight ( kg ) / 72 x serum creat ( mg/dl ) , Men = ( 140 age ) x body weight ( kg ) / 72 x serum creat ( mg/dl ) , patient renal transplant ; 9 . Anemia ( Hgb &lt; 8 gm/dl ) ; 10 . Thrombocytopenia ( platelet count &lt; 100 x 109/L ) ; 11 . Liver disease demonstrate ALT &gt; 144u/L 12 . Uncontrolled hypertension ( systolic blood pressure &gt; 180mmHg diastolic blood pressure &gt; 100mmHg ) ; 13 . Life expectancy le 6 month ; 14 . Moderate pericardial effusion diagnose echo ; 15 . Concomitant use clopidogrel , cyclooxygenase 1 2 inhibitor use within seven day ; Non medical exclusion 1 . Patients unable unwilling provide consent . 2 . Patients unable unwilling followup echocardiogram .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>mechanical valve replacement</keyword>
	<keyword>warfarin</keyword>
</DOC>